Skip to main content
. 2023 Mar 10;9:37. doi: 10.1186/s40814-023-01244-y

Table 2.

Personal and medical characteristics of participants

Yoga intervention participants (only)§ Study participants
Personal factors
 Age 33.84 (6.06) 34.20 (5.09)
 Location (n)
  Alberta 42 16
  British Columbia 09 02
  Manitoba 05 01
  New Brunswick 01 01
  Newfoundland and Labrador 04 01
  Northwest Territories 01 00
  Nova Scotia 02 00
  Nunavut 00 00
  Ontario 19 06
  Prince Edward Island 00 00
  Quebec 04 00
  Saskatchewan 05 03
  Yukon 00 00
 Setting (n)
  Urban location (defined as > 100,000 people) 24
  Rural/remote location (defined as all non-urban locations) 06
 Biological sex (n)
  Female 28
  Male 02
 Current gender (n)
  Female 27
  Male 02
  Others 01
 Marital status (n)
  Never married 10
  Married 14
  Common law 06
 Education (highest level attained) (n)
  Some university/college 02
  Completed university/college 19
 Some graduate school 03
  Completed some graduate school 06
 Annual income
  < $20,000 01
  Between $20,000 and $39,000 02
  Between $40,000 and $59,000 03
  Between $60,000 and $79,000 05
  Between $80,000 and $99,000 07
  > $100,000 12
 Employment status (n)
  Disability 11
  Part-time 09
  Homemaker 01
  Full-time 08
  Temporarily unemployed 01
 Ethnicity (n)
  British 15
  Western European 17
  Eastern European 08
  Northern European 04
  Southern European 01
  Aboriginal 01
  East and Southern Asia 02
  Southern Asia 01
  Western Asia 00
  Pacific Islands 01
  Arab 00
  Latin/Central and South America 01
  Caribbean 00
  African 00
  Others
Medical factors
 Diagnosis (n)
  Blood 18 09
  Breast 34 13
  Digestive 07 00
  Genitourinary 01 00
  Gynecological 03 01
  Head and neck 04 01
  Lung 02 01
  Metastases 08
  Neurological 02 02
  Others 03 01
  Skin 01 01
  Thyroid 06 02
 Treatment status (n)
  On-treatment 14
  Off-treatment 13
 On-treatment (current treatment) (n)
  Surgery 0
  Chemotherapy 4
  Radiation 00
  Hormone therapy 11
  Biological therapy 01
  Others 02
 On-treatment (completed treatment) (n)
  Surgery 13
  Chemotherapy 11
  Radiation 09
  Hormone therapy 01
  Biological therapy 01
  Others 03
 Off-treatment (completed treatment) (n)
  Surgery 07
  Chemotherapy 07
  Radiation 05
  Hormone therapy 00
  Biological therapy 00
  Others 02
 Diagnosis date
  1990–1995 01 00
  1995–2000 00 00
  2001–2005 01 00
  2006–2010 02 00
  2011–2015 12 05
  2016–2020 74 25
  Not provided 02 00
 Symptoms (n)‡ 
  Fatigue 25
  Pain 16
  Lymphedema (swelling) 05
  Peripheral neuropathy (tingling, numbness) or other nerve damages 17
  Osteoporosis or bone loss 02
  Ostomy (colostomy, ileostomy, J-pouch, urostomy) 00
  Cognitive challenges (learning or memory problems, chemo brain, brain fog) 18
  Weight maintenance issues 13
  Breathing issues 06
  Heart issues 02
  Communication issues (speaking or hearing) 02
  Others 02

“–” indicates that data were not collected

§Young adults affected by cancer at baseline (week 0), who had completed at least one session

Mean (SD)

Participants could select 'all that apply'